MDxHealth SA ADR Total Liabilities
MDxHealth SA ADR total liabilities. Based on the latest financial reports, MDxHealth SA ADR (MDXH) has total liabilities worth $162.49 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check MDxHealth SA ADR liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of MDxHealth SA ADR (2004–2025)
Total liabilities of MDxHealth SA ADR from 2004 to 2025. This chart illustrates how MDxHealth SA ADR's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of MDxHealth SA ADR to see how much of total assets are deployed in long-term investments.
MDxHealth SA ADR Competitors by Total Liabilities
The table below lists competitors of MDxHealth SA ADR ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Stellar Resources Ltd
AU:SRZ
|
Australia | AU$621.89K |
|
Heidelberg Pharma AG
F:HPHA
|
Germany | €43.94 Million |
|
GalaxiaMoneytree Co.Ltd
KQ:094480
|
Korea | ₩297.44 Billion |
|
Paramount Gold Nevada Corp
NYSE MKT:PZG
|
USA | $27.62 Million |
|
Bajaj Healthcare Limited
NSE:BAJAJHCARE
|
India | Rs3.90 Billion |
|
Ice Make Refrigeration Limited
NSE:ICEMAKE
|
India | Rs-1.33 Billion |
|
Clal Industries and Beverages Ltd
TA:CLBV
|
Israel | ILA309.55 Million |
|
Business Alignment Public Company Limited
BK:BIZ
|
Thailand | ฿934.33 Million |
Liability Composition Analysis (2004–2025)
This chart breaks down MDxHealth SA ADR's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see MDxHealth SA ADR balance sheet assets.
Liquidity & Leverage Metrics
MDxHealth SA ADR Total Liabilities Ratios Explained
MDxHealth SA ADR total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -5.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MDxHealth SA ADR's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MDxHealth SA ADR (2004–2025)
The table below shows the annual total liabilities of MDxHealth SA ADR from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $160.05 Million | +12.32% |
| 2024-12-31 | $142.49 Million | +16.87% |
| 2023-12-31 | $121.92 Million | +11.02% |
| 2022-12-31 | $109.82 Million | +289.81% |
| 2021-12-31 | $28.17 Million | +8.33% |
| 2020-12-31 | $26.01 Million | +24.41% |
| 2019-12-31 | $20.90 Million | +56.48% |
| 2018-12-31 | $13.36 Million | -10.79% |
| 2017-12-31 | $14.97 Million | -0.03% |
| 2016-12-31 | $14.98 Million | +11.13% |
| 2015-12-31 | $13.48 Million | +87.82% |
| 2014-12-31 | $7.18 Million | +48.07% |
| 2013-12-31 | $4.85 Million | +21.88% |
| 2012-12-31 | $3.98 Million | -9.01% |
| 2011-12-31 | $4.37 Million | -11.09% |
| 2010-12-31 | $4.92 Million | -42.36% |
| 2009-12-31 | $8.53 Million | -4.42% |
| 2008-12-31 | $8.92 Million | +5.83% |
| 2007-12-31 | $8.43 Million | +33.18% |
| 2006-12-31 | $6.33 Million | +30.25% |
| 2005-12-31 | $4.86 Million | +182.49% |
| 2004-12-31 | $1.72 Million | -- |
About MDxHealth SA ADR
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the… Read more